|
|
Gene Symbol |
MMP2 |
|
Aliases |
CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1 |
|
Entrez Gene ID |
|
|
Gene Name |
Matrix metallopeptidase 2 |
|
Chromosomal Location |
16q12.2 |
|
HGNC ID |
|
|
Summary |
This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
72 kDa type IV collagenase, collagenase type IV-A, matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase), matrix metalloproteinase-2, matrix metalloproteinase-II, neutrophil gelatinase |
|
Function |
Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture. As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidative stress by regulating the activity of GSK3beta. Cleaves GSK3beta in vitro. Involved in the formation of the fibrovascular tissues in association with MMP14.; PEX, the C-terminal non-catalytic fragment of MMP2, posseses anti-angiogenic and anti-tumor properties and inhibits cell migration and cell adhesion to FGF2 and vitronectin. Ligand for integrinv/beta3 on the surface of blood vessels.; [Isoform 2]: Mediates the proteolysis of CHUK/IKKA and initiates a primary innate immune response by inducing mitochondrial-nuclear stress signaling with activation of the pro-inflammatory NF-kappaB, NFAT and IRF transcriptional pathways |
|
|
|
|
|
UniProt |
|
|
PDB |
3AYU, 1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000230588 |
Q16819 |
Q16819 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Aortic Rupture |
|
Myocardial Infarction |
|
Aortic Aneurysm |
|
Hypertensive disease |
|
Aortic Diseases |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Marfan Syndrome |
|
Digestive System Diseases |
Liver Cirrhosis |
|
Liver Diseases |
|
Liver Fibrosis |
|
Oral submucosal fibrosis |
|
Hepatitis |
|
Cholestasis |
|
Endocrine System Diseases |
Diabetic Neuralgia |
|
PCOS |
|
Immune System Diseases |
Rheumatoid Arthritis |
|
Lupus Nephritis |
|
Musculoskeletal Diseases |
Torg-Winchester Syndrome |
|
Maxillary Diseases |
|
Temporomandibular Joint Disorders |
|
Bone Diseases |
|
Kienbock Disease |
|
Neoplasms |
Breast Cancer |
|
Nasopharyngeal Cancer |
|
Colorectal Cancer |
|
Liver Cancer |
|
Nose Cancer |
|
Bone Neoplasms |
|
Osteosarcoma |
|
Glioblastoma |
|
Glioblastoma Multiforme |
|
Genital Neoplasms, Male |
|
Mouth Neoplasms |
|
Vulvar Cancer |
|
Nervous System Diseases |
Diabetic Neuropathies |
|
Nutritional and Metabolic Diseases |
Tumoral calcinosis |
|
Metabolic Bone Disorder |
|
Osteopenia |
|
Reproductive disorders |
Preeclampsia |
|
Respiratory Tract Diseases |
Emphysema |
|
Pulmonary Fibrosis |
|
Pulmonary Emphysema |
|
Skin and Connective Tissue Diseases |
Leishmaniasis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
MMP-9 and TIMP-1 |
Follicular atresia, formation of multiple ovarian cysts |
|
|
Related
|
|
Thus the MMP-TIMP balance is shifted toward greater MMP activity in luteinized granulosa cells from women with PCOS |
|
MMP-9, TIMP-1 |
Cardiovascular risk,menstrual irregularities |
|
Rotterdam criteria |
Related
|
|
Obese women with PCOS have elevated serum concentrations of MMP-2 and -9. |
|
MMP-9, TIMP-1, TIMP-2 |
|
|
|
Related
|
|
Significantly higher levels of MMP-2 and MMP-9 were found in the PCOS group compared to controls. |
|
MMP-8, MMP-9, TIMP-1, TIMP-2 |
|
|
|
Related
|
|
We found higher MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in PCOS patients than in healthy controls |
|
AP-1,EGR-1,TF |
Chronic low-grade inflammation,atherothrombosis,hyperandrogenism |
|
Rotterdam criteria |
Related
|
|
Lean women with PCOS exhibited greater AP-1 activation and MMP2 protein content after glucose ingestion and higher plasma MMP9 and CRP levels than lean controls |
|
|
|
|